| Ticker Details |
|
TransMedics Group, Inc.
|
| IPO Date: |
April 29, 2019 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$2.49B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.81 | 3.14%
|
| Avg Daily Range (30 D): |
$1.88 | 2.57%
|
| Avg Daily Range (90 D): |
$2.92 | 3.03%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.56M |
| Avg Daily Volume (30 D): |
.98M |
| Avg Daily Volume (90 D): |
1.09M |
| Trade Size |
| Avg Trade Size (Sh.): |
49 |
| Avg Trade Size (Sh.) (30 D): |
43 |
| Avg Trade Size (Sh.) (90 D): |
45 |
| Institutional Trades |
| Total Institutional Trades: |
3,369 |
| Avg Institutional Trade: |
$3.82M |
| Avg Institutional Trade (30 D): |
$4M |
| Avg Institutional Trade (90 D): |
$4.02M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.38M |
| Avg Closing Trade (30 D): |
$9.76M |
| Avg Closing Trade (90 D): |
$9.85M |
| Avg Closing Volume: |
69.13K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$5.05
|
$.21
|
$3.1
|
|
Diluted EPS
|
$4.37
|
$.2
|
$2.59
|
|
Revenue
|
$635.89M
|
$173.93M
|
$160.76M
|
|
Gross Profit
|
$375.74M
|
$101.16M
|
$93.41M
|
|
Net Income / Loss
|
$171.92M
|
$7.32M
|
$105.38M
|
|
Operating Income / Loss
|
$94.44M
|
$13.3M
|
$21.27M
|
|
Cost of Revenue
|
$260.15M
|
$72.77M
|
$67.35M
|
|
Net Cash Flow
|
$169.53M
|
$-8.69M
|
$22.19M
|
|
PE Ratio
|
|
|
|
|
|
|